Clinical Trial Update: Studying Biomarkers in Samples From Patients With High-Risk Neuroblastoma

View source ↗

Summary

An update on a completed clinical trial studying biomarkers in samples from patients with high-risk neuroblastoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroblastoma

Snippet

Sponsor: Children's Oncology Group | Conditions: Neuroblastoma | Status: COMPLETED